BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35812867)

  • 1. Epidemiological Investigation of Canine Mammary Tumors in Mainland China Between 2017 and 2021.
    Zheng HH; Du CT; Yu C; Zhang YZ; Huang RL; Tang XY; Xie GH
    Front Vet Sci; 2022; 9():843390. PubMed ID: 35812867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiological Study of Mammary Tumors in Female Dogs Diagnosed during the Period 2002-2012: A Growing Animal Health Problem.
    Salas Y; Márquez A; Diaz D; Romero L
    PLoS One; 2015; 10(5):e0127381. PubMed ID: 25992997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of mammary tumors in the canine population living in the Veneto region (Northeastern Italy): Risk factors and similarities to human breast cancer.
    Vascellari M; Capello K; Carminato A; Zanardello C; Baioni E; Mutinelli F
    Prev Vet Med; 2016 Apr; 126():183-9. PubMed ID: 26948297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canine mammary gland disease in New Zealand: a review of samples from 797 dogs.
    Ariyarathna H; Aberdein D; Thomson N; Gibson I; Munday JS
    N Z Vet J; 2022 Mar; 70(2):95-100. PubMed ID: 34756151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canine Spindle Cell Mammary Tumor: A Retrospective Study of 67 Cases.
    Alonso-Diez Á; Ramos A; Roccabianca P; Barreno L; Pérez-Alenza MD; Tecilla M; Avallone G; Gama A; Peña L
    Vet Pathol; 2019 Jul; 56(4):526-535. PubMed ID: 30857503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Statistical Analysis of Risk Factors and Biological Behavior in Canine Mammary Tumors: A Multicenter Study.
    Burrai GP; Gabrieli A; Moccia V; Zappulli V; Porcellato I; Brachelente C; Pirino S; Polinas M; Antuofermo E
    Animals (Basel); 2020 Sep; 10(9):. PubMed ID: 32961915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying the Risk Factors for Malignant Mammary Tumors in Dogs: A Retrospective Study.
    da Silva EMG; Dos Santos TR; Silva MJB
    Vet Sci; 2023 Oct; 10(10):. PubMed ID: 37888559
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Sánchez D; Romero L; López S; Campuzano M; Ortega R; Morales A; Guadarrama M; Cesarman-Maus G; García-Pérez O; Lizano M
    Front Vet Sci; 2019; 6():280. PubMed ID: 31508434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-expression of klotho in canine mammary gland tumors and its prognostic significance.
    Chung H; Lee S; Kim GA; Kim WH
    PLoS One; 2022; 17(6):e0265248. PubMed ID: 35666743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of Global DNA Methylation in Canine Mammary Gland Tumors
    Biondi LR; Tedardi MV; Gentile LB; Chamas PPC; Dagli MLZ
    Front Vet Sci; 2021; 8():628241. PubMed ID: 33718471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased levels of interleukins 8 and 10 as findings of canine inflammatory mammary cancer.
    de Andrés PJ; Illera JC; Cáceres S; Díez L; Pérez-Alenza MD; Peña L
    Vet Immunol Immunopathol; 2013 Apr; 152(3-4):245-51. PubMed ID: 23351639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A canine model of familial mammary gland neoplasia.
    Schafer KA; Kelly G; Schrader R; Griffith WC; Muggenburg BA; Tierney LA; Lechner JF; Janovitz EB; Hahn FF
    Vet Pathol; 1998 May; 35(3):168-77. PubMed ID: 9598580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ki-67 and PCNA Expression in Canine Mammary Tumors and Adjacent Nonneoplastic Mammary Glands: Prognostic Impact by a Multivariate Survival Analysis.
    Carvalho MI; Pires I; Prada J; Lobo L; Queiroga FL
    Vet Pathol; 2016 Nov; 53(6):1138-1146. PubMed ID: 27162119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative treatment outcome in canine mammary tumors. Multivariate analysis of the prognostic value of pre- and postoperatively available information.
    Betz D; Schoenrock D; Mischke R; Baumgärtner W; Nolte I
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2012; 40(4):235-42. PubMed ID: 22911254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CEA, CA 15-3, and miRNA expression as potential biomarkers in canine mammary tumors.
    Jain M; Ingole SD; Deshmukh RS; Bharucha SV; Nagvekar AS; Gaikwad RV; Kharde SD
    Chromosome Res; 2021 Jun; 29(2):175-188. PubMed ID: 33638118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic significance of angiogenesis in canine mammary tumors.
    Graham JC; Myers RK
    J Vet Intern Med; 1999; 13(5):416-8. PubMed ID: 10499723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunocytochemical study of Ki-67 as a prognostic marker in canine mammary neoplasia.
    Zuccari DA; Santana AE; Cury PM; Cordeiro JA
    Vet Clin Pathol; 2004; 33(1):23-8. PubMed ID: 15048623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA Methylation Status of the Estrogen Receptor α Gene in Canine Mammary Tumors.
    Brandão YO; Toledo MB; Chequin A; Cristo TG; Sousa RS; Ramos EAS; Klassen G
    Vet Pathol; 2018 Jul; 55(4):510-516. PubMed ID: 29566609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of karyometric variables in spontaneously occurring canine mammary tumors.
    Nair BC; Kumar S; Rani S; Paliwal OP
    Anal Quant Cytol Histol; 2006 Oct; 28(5):292-6. PubMed ID: 17067011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The activity of matrix metalloproteinases (MMPS) and tissue inhibitors of metalloproteinases (TIMPs) in mammary tumors of dogs and rats.
    Kawai K; Uetsuka K; Doi K; Nakayama H
    J Vet Med Sci; 2006 Feb; 68(2):105-11. PubMed ID: 16520530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.